One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

▎药明康德内容团队编辑  12年前，一名不到7岁的小女孩急性淋巴细胞白血病复发，危在旦夕。幸运的是，她接受了一项史无前例的治疗——医生们从她的身体里分离出一部分T细胞，先在实验室里对其进行基因改造，让这些细胞有能力识别癌细胞；随后，改造后的T细胞经过 ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Discover the groundbreaking research combining DNase I with CAR T-cell therapy to enhance cancer treatment efficacy, suppress ...

CAR-T，这一开创性的免疫疗法，凭借其精准的靶向性和低毒性，已成为治疗众多血液系统恶性肿瘤的革命性突破。全球范围内，已有13款CAR-T产品成功获批上市，为复发性及难治性肿瘤的治疗带来了显著希望。

CARGO Therapeutics, Inc. (CRGX) has received a new Buy rating, initiated by William Blair analyst, Sami Corwin.Don't Miss our Black Friday ...

Roche RHHBY announced that it will acquire clinical-stage biopharmaceutical company Poseida Therapeutics, Inc. PSTX for $9 ...

Findings suggest GD2-specific CAR T-cell therapy is a viable option for H3K27M-mutant gliomas, with significant tumor ...

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...